XSHG
688029
Dec 05, Last price
79.58
1D
1.26%
1Q
-12.26%
IPO
-9.76%
Name
Micro-Tech Nanjing Co Ltd
Chart & Performance
P/E
—
P/S
—
EPS
2.96
Div Yield, %
1.88%
Shrs. gr., 5y
3.30%
Rev. gr., 5y
%
Revenues
2.76b
+14.26%
Net income
553m
+13.85%
CFO
613m
+12.36%
Dividend
Oct 11, 20240.5 /sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Micro-Tech (Nanjing) Co., Ltd. manufactures and sells non-vascular stents and disposable biopsy forceps primarily in China, Europe, North America, Oceania, etc. The company offers gastroenterology products, such as biliary (longwire), biliary (shortwire), biopsy, dilation and hemostasis products, EUS, nitinol stents, resection products, retrieval devices, and accessories; and pulmonology products, such as airway stents, biopsy, dilation balloons, cytology brushes, retrieval devices, and accessories. The company also offers OEM/ODM services to companies in the medical devices field. Micro-Tech (Nanjing) Co., Ltd. was founded in 1999 and is based in Nanjing, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||